Mumbai, Aug 26: Pharma Major Unichem Laboratories said that The United States Food and Drug Administration (USFDA) conducted inspection at company's Ghaziabad formulation facility between August 19, 2019 to August 23, 2019. The inspection was a routine GMP surveillance.
At the end of Inspection, the facility received 1 (one) observation which is not a repeat observation and is procedural in nature, company said in a filing with BSE. Unichem will provide the response and corrective action plan within next 15 working days to address the USFDA observation. UNI